Supplier
Caritas ST. Elizabeth Medical Center
Caritas ST. Elizabeth Medical Center was paid $94K by Medicaid between Jan 2018 and Sep 2024, across 28 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 63% of everything it billed.
33Billing provider infoCARITAS ST. ELIZABETH MEDICAL CENTER
BOSTON, MA 02135
BOSTON, MA 02135
33aNPI1225168768assigned 03/06/2007
33bProvider typeDurable Medical Equipment & Medical Supplies
28Total paid$94K
24GClaims17,246
24DCodes billed28
24AFirst – last monthJan 2018 – Sep 2024
Compared with peers
Next to other Durable Medical Equipment & Medical Supplies providers in Massachusetts
Rank by total paid#82 of 297
Median peer was paid$0.00
This provider vs. median0.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,555 | $12K | |
| 2019 | 3,389 | $15K | |
| 2020 | 1,957 | $5K | |
| 2021 | 2,406 | $6K | |
| 2022 | 2,461 | $13K | |
| 2023 | 2,616 | $22K | |
| 2024incomplete | 1,862 | $20K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 63% | 10,844 | 9,141 | $59K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 20% | 266 | 258 | $19K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 4.0% | 133 | 124 | $4K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 3.4% | 84 | 79 | $3K |
| 71046 | Radiologic examination, chest; 2 views | 2.2% | 286 | 278 | $2K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.2% | 574 | 170 | $1K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.1% | 169 | 169 | $1K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,980 | 1,888 | $899.65 |
| G0008 | Administration of influenza virus vaccine | <1% | 411 | 411 | $751.47 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 181 | 174 | $600.00 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 27 | 25 | $427.89 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 81 | 78 | $410.64 |
16 more codes
| 20610 | <1% | 13 | $294.12 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 169 | $270.17 |
| Q3014 | Telehealth originating site facility fee | <1% | 795 | $254.69 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 153 | $150.00 |
| 90662 | <1% | 164 | $139.03 | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 24 | $117.77 |
| Q2038 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | <1% | 84 | $34.10 |
| 36415 | Collection of venous blood by venipuncture | <1% | 529 | $23.94 |
| 90688 | <1% | 80 | $22.78 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 32 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 81 | $0.00 |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 25 | $0.00 |
| 36416 | 0% | 14 | $0.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 13 | $0.00 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 22 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFUSARO, ERNIE (DIRECTOR)